GSA Capital Partners LLP acquired a new stake in National Research Co. (NASDAQ:NRC – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 14,457 shares of the company’s stock, valued at approximately $330,000.
Other institutional investors have also modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC grew its stake in National Research by 0.6% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,045,306 shares of the company’s stock worth $69,890,000 after purchasing an additional 18,891 shares in the last quarter. Vanguard Group Inc. grew its stake in National Research by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 944,995 shares of the company’s stock worth $37,431,000 after purchasing an additional 10,351 shares in the last quarter. Renaissance Technologies LLC grew its stake in National Research by 14.4% during the 2nd quarter. Renaissance Technologies LLC now owns 432,884 shares of the company’s stock worth $9,935,000 after purchasing an additional 54,600 shares in the last quarter. Millennium Management LLC grew its stake in National Research by 200.9% during the 2nd quarter. Millennium Management LLC now owns 214,858 shares of the company’s stock worth $4,931,000 after purchasing an additional 143,454 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its stake in National Research by 5.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 123,255 shares of the company’s stock worth $2,829,000 after purchasing an additional 6,295 shares in the last quarter. 47.26% of the stock is owned by institutional investors and hedge funds.
National Research Stock Down 1.7 %
Shares of NASDAQ NRC opened at $19.12 on Friday. The company has a market capitalization of $448.86 million, a price-to-earnings ratio of 16.92 and a beta of 0.51. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. The business has a 50-day moving average of $19.96 and a two-hundred day moving average of $23.24. National Research Co. has a 1 year low of $17.62 and a 1 year high of $42.19.
National Research Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.51%. The ex-dividend date is Friday, December 27th. National Research’s payout ratio is currently 42.48%.
National Research Company Profile
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Read More
- Five stocks we like better than National Research
- The 3 Best Retail Stocks to Shop for in August
- Tesla Investors Continue to Profit From the Trump Trade
- What Do S&P 500 Stocks Tell Investors About the Market?
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Election Stocks: How Elections Affect the Stock Market
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Want to see what other hedge funds are holding NRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Co. (NASDAQ:NRC – Free Report).
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.